Delivered-To: tjphuhs@gmail.com Received: by 2002:adf:ef46:0:b0:441:282b:bd with SMTP id c6csp1257479wrp; Mon, 4 May 2026 05:22:44 -0700 (PDT) X-Received: by 2002:a05:6214:4d06:b0:8ac:732b:6cf1 with SMTP id 6a1803df08f44-8b6682579b0mr142994796d6.24.1777897364018; Mon, 04 May 2026 05:22:44 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1777897364; cv=none; d=google.com; s=arc-20240605; b=ahgjJXEMEwbfpRBKd7P/WsgI2F541Fe3KWrbNB650CE7n1pFd0w8A/A5tg4CIXx/AD Oavx3JpE+frP0eaHtaVmDzL4fYtwYKoqiWSZiYJeoHe0QacmF+c7Uur9tq1kwMxrDvJV Xi7KL+6me81oBLbuU20BLqC85FI/tS4lhlUJnE7ZWvoHXPkIDoDJkRHdq6lUWPw0dNo7 T0D3J3dYFfpb31OluQ/T/uIo16m9FEzGwpwQuQlUPcgZCIZVPU1w0NFfvjzfd+3EY/YZ HlYSbJBjWHT1wtiw7VyQ69LMVgbPpZto4kAs1gn0GFe4klS/3mRTqE/hsG2Z7VsLHHNo oGKw== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=to:subject:message-id:mime-version:from:date:dkim-signature :dkim-signature; bh=GbqzrmkkKNdMinerigLTUK1HKSfMTM931dWsGOdtDXg=; fh=HRf6yyghNOjQDshkl9V8M2R5zVUW8nIXxjp8HF/gBco=; b=FT0HbvZFra32k0WpLfO2W128gtoWYrN+f8pkpnEO3AeIHrDDSbsH2xboln3joWjMBv 2KrTJ/+q3sgigOmz5nycfP5xEAbxW64IKdsXUE7DmtNl75mSUR5w/BRD2kAqMlG2yxic i8gUS+LqJ7aIawX47U97nwFt1UzzyM7XpVOF1LbrZicssqPN5qfBiiSoK4BA6LdGvaG6 iRzxMobawAZa5+Lj/Pju+3jYHh8SegZqIfPfq4DeksyaxV1HV5ARWmMVTL92TCKACg5m 49xbJ+Yelk6gseuqs+rLjFntzIROVyn0lZIfGaERFmOw3Cn0BCuyWGRFMtjqJTlaY52s +4Ew==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@skool.com header.s=m1 header.b=iipnDxi1; dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=JwiVxGML; spf=pass (google.com: domain of bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com designates 149.72.44.169 as permitted sender) smtp.mailfrom="bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com"; dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=skool.com Return-Path: Received: from o1.ptr7400.skool.com (o1.ptr7400.skool.com. [149.72.44.169]) by mx.google.com with ESMTPS id 6a1803df08f44-8b53bcfde00si112623476d6.297.2026.05.04.05.22.43 for (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128); Mon, 04 May 2026 05:22:43 -0700 (PDT) Received-SPF: pass (google.com: domain of bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com designates 149.72.44.169 as permitted sender) client-ip=149.72.44.169; Authentication-Results: mx.google.com; dkim=pass header.i=@skool.com header.s=m1 header.b=iipnDxi1; dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=JwiVxGML; spf=pass (google.com: domain of bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com designates 149.72.44.169 as permitted sender) smtp.mailfrom="bounces+51791150-dbea-tjphuhs=gmail.com@mail.skool.com"; dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=skool.com DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=skool.com; h=content-type:date:from:mime-version:subject:to:cc:content-type:date: feedback-id:from:subject:to; s=m1; t=1777897363; bh=GbqzrmkkKNdMinerigLTUK1HKSfMTM931dWsGOdtDXg=; b=iipnDxi1WUr03fSCezumsPWc1e/kDSubbeXSrH9YwK82Km8BbLvyw5rhwH76bpUmvLDz 8z9mckaJ6HTZpeGLAR+aWYMM3yQ77xFEadzTyQ5eq9ipf5oE8ESyafv698YH1NMRUxDg2+ HGAPwoSZDQLLs6U8p5wO8/pHv6/UMT2io= DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info; h=content-type:date:from:mime-version:subject:to:cc:content-type:date: feedback-id:from:subject:to; s=smtpapi; t=1777897363; bh=GbqzrmkkKNdMinerigLTUK1HKSfMTM931dWsGOdtDXg=; b=JwiVxGMLbWdspUD3yTN/IYyKtZxrqa/S/E65ZhMNEnYRb1qzWva8/HZuuQRlgXd8gUNg BDuOQR/xC83uNA4vPMPIE1KAqrrRunamSErooZXnaz+kUJ54TSu5nQuL4ja44VbqauXCEG PzcMH4iheHiLlrj40Len2NzQ3eL/KqrfA= Received: by recvd-64c5799497-6dh6r with SMTP id recvd-64c5799497-6dh6r-1-69F88F93-51 2026-05-04 12:22:43.392032275 +0000 UTC m=+485449.579052856 Received: from NTE3OTExNTA (unknown) by geopod-ismtpd-5 (SG) with HTTP id y6W2KaIjQRekGn62GDjvnw Mon, 04 May 2026 12:22:43.344 +0000 (UTC) Content-Type: multipart/alternative; boundary=631f8bd3c8591f5239b52090df7807df2a25fbf39b2144a73ca69dd83b11 Date: Mon, 04 May 2026 12:22:43 +0000 (UTC) From: "Peptide Research Forum (Skool)" Mime-Version: 1.0 Message-ID: Subject: 6 new notifications since 8:22 am (May 3, 2026) X-SG-EID: =?us-ascii?Q?u001=2EubHp4JcR5c901DNKInUyPm7dF=2FCf7fvbvoo6xAmK=2Fk3zuItGn=2FgZbslI6?= =?us-ascii?Q?dj8O0MuTGOgjtZrhg72gRCz8gNM6s71ivCV5KCc?= =?us-ascii?Q?hyUI7=2Fpb686jX9dyb5cP3IAv89+caN9nld=2Fq6Eq?= =?us-ascii?Q?ixDnEfjQV2ekzvDCK0383eEWDxICAd=2Fvz2iQ30n?= =?us-ascii?Q?PK0FIH4Dpp=2FyMxn1dqfJ4T1dHfFV8RbsXBhU26=2F?= =?us-ascii?Q?hLz=2Fu2HEBbgjNbIJWafHOTYOxf=2F+nCWCTkNUlKF?= =?us-ascii?Q?VJC7?= X-SG-ID: =?us-ascii?Q?u001=2ESdBcvi+Evd=2FbQef8eZF3Bn0=2F1wqYKdPmI+SecjXfzkexw5XZq85qJVoOl?= =?us-ascii?Q?n8C3YWz=2F2mp6FhFOiIkITN0GVhdexpOb4ZxPAF1?= =?us-ascii?Q?BfRaNIWXBtLErChd3Xz3dH4nRccHJYSbOGOPqWQ?= =?us-ascii?Q?EoUtZ7Mjja8RT8YpQC8YKB5isByb50eTUJEMUMJ?= =?us-ascii?Q?r+L13g=2FYpCxfvR8mSc=2FAqsUUmYeE=2FSDytNAuPQW?= =?us-ascii?Q?wtcofAFqR3U3Gs3M3w95y9bD7+ISmittRCJa34S?= =?us-ascii?Q?+VkdFDBGm9aMSYxGTD+AYPmwiybN2tGqOGgrnzn?= =?us-ascii?Q?EbL44FdxWgGt4VVa7sXQ1Dhy5YnV6rF+Bv=2FtVqm?= =?us-ascii?Q?Zg8B74i5LyfQ=3D=3D?= To: Tj B X-Entity-ID: u001.YyfUs6GcaMiTWcD8cP6Peg== --631f8bd3c8591f5239b52090df7807df2a25fbf39b2144a73ca69dd83b11 Content-Transfer-Encoding: quoted-printable Content-Type: text/plain; charset=utf-8 Mime-Version: 1.0 Peptide Research Forum ( https://link.skool.com/ls/click?upn=3Du001.wK6x93jhdVos-2F3TofGJCJqYIach7= -2FtMhH3n-2Fh9qG9l0GnWL4PQOS-2FZ5VkS4LpRux6cLnt8iwWzMy60vV13NsmSkVAqQ6xINO8= 4lL5vgJGcj25AcC730epr-2BJNkMe2b11hUGBGOEDRjk0X9uh69usMpBfU47CevKCj2xPbbrrAQ= bVlKyWmpBwUC5bK4S5yQnUp-2Bn7ZVR9P0XvxtrxvYbnxS12vq4bPvD9aAV4Fhfh1iBI-2B1TBx= 2dtzuTT4gPjAa40xiik_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNVm36Mi3FeCFXPl9pgXHZ= bouoZDfMirbSqMZm-2FwCpxRYcmA17BXWTABPQMIzeWxAz4sHlnYR-2B0Ld41QUUDxUUcJIcRW0= VIex5IV8vc-2Bvl1Ku0o84lw9t0Z3ySqXoFBjA6iJGBMF5FgRvu4Zx-2B-2BxiG29OzRR3-2FLH= NRZMi9vM83iHNezo-2B4DvMgFDqMLp-2BAo-2BCYqkw9oLe44e7pMQnLfLcDhxbdF0xBY4wvSds= MJZ-2BXr6GPOOb7q4NrS9aYjG3hjsSrLLDUQMASzUyU5XIzsdLwP1wpCg2fFqX3GPi2lXs9PJcD= lyPnUkX-2B8cZK5UsWwJd0uXbnYk1kzsmgevOZJ-2FuqSdSL9g7iF9-2B7Fl5MBS7tS4k6pNP9Y= aVSUaQg0C9Y9RztW2ZFIwRfDDkPXmBPGeCR7i08WkfuLNDrqkpOcmheKcw0uauHKm-2F-2BTDDX= HUTxZAoxv4PkJb4HBZF40CVDvL23LcDWDTl4qvFw-2Bw9zP0EvDN5fcCeFFF0rg-3D-3D ) ************************* 6 new notifications ************************* Since 8:22 am (May 3, 2026) Here=E2=80=99s what you missed: =20 =20 CA =20 ( ) ( ) =20 PR =20 ( ) ( ) View Group ( https://link.skool.com/ls/click?upn=3Du001.wK6x93jhdVos-2F3TofGJCJpQRf55z= hr7DNm-2FR-2BmY-2BDj9GgSvbCQayKKmJXcqFElFErDpKFgfmxhqq-2BQH7PKNNLw-3D-3D33j= q_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNVm36Mi3FeCFXPl9pgXHZbouoZDfMirbSqMZm-2= FwCpxRYcmA17BXWTABPQMIzeWxAz4sHlnYR-2B0Ld41QUUDxUUcJIcRW0VIex5IV8vc-2Bvl1Ku= 0o84lw9t0Z3ySqXoFBjA6iJGBMF5FgRvu4Zx-2B-2BxiG29OzRR3-2FLHNRZMi9vM83iHNezo-2= B4DvMgFDqMLp-2BAo-2BCYqkw9oLe44e7pMQnLfLcDhxbdF0xBY4wvSdsMJZ-2BXr6GPOOb7q4N= rS9aYjG3hjsSrLLDUQMASzUyU5XIzsdLwP1wpCg2fFqX3GPi2lXs9PJcDlyPnUkX-2Bx8IbgvDM= s6UIvk7-2BVY2Oq-2FGH96YR2nF6oPSOMBjXvaHfBUt5Nltp4kNp9WKoAo5Vwi48ISIwPqZiMFq= GVhkNushp8UpFtiUia5HrPW-2BGkBr1yGw6W8TkMZtsnedYAxjfWBitB7TImqPnH1pN-2B5lh-2= B2xDtocqwjyOcEyqUBzoBE4fxKlh-2F9erPZ-2F49fKpIDh6g-3D-3D ) Are we sending you too many emails? We=E2=80=99re bundling up all your email notifications: Daily Change to: Hourly ( https://link.skool.com/ls/click?upn=3Du001.wK6x93jhdV= os-2F3TofGJCJv2x-2FXYKi-2F266Yv7HF2lGr2lKEDUFdUmJbSqgmJ4GHGXwdeLAhi0ttQVU-2= BJn-2FSc7eLHj-2FjQ57b6DwiDwnULkhHGGM5nTBuwdENAEYeRWG40Jba3CElDV2vcKLX2IjWsL= 61NPA7YVvJ-2BV7lLeKjugkQtBEIrQ1SN83tPWnhWTsgiQaHXFWmoL-2B0X0YkcYWwv42orXFsL= MSURkRx34JKNcJps-3DIMN1_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNVm36Mi3FeCFXPl9p= gXHZbouoZDfMirbSqMZm-2FwCpxRYcmA17BXWTABPQMIzeWxAz4sHlnYR-2B0Ld41QUUDxUUcJI= cRW0VIex5IV8vc-2Bvl1Ku0o84lw9t0Z3ySqXoFBjA6iJGBMF5FgRvu4Zx-2B-2BxiG29OzRR3-= 2FLHNRZMi9vM83iHNezo-2B4DvMgFDqMLp-2BAo-2BCYqkw9oLe44e7pMQnLfLcDhxbdF0xBY4w= vSdsMJZ-2BXr6GPOOb7q4NrS9aYjG3hjsSrLLDUQMASzUyU5XIzsdLwP1wpCg2fFqX3GPi2lXs9= PJcDlyPnUkX-2B0gKAV48gnPOPsEpTbOAsx4HP-2F1dmeDOyJNNdWVX1sdbUhUNuKf3VpHX2-2B= 6XlcNCm5eBlpfyd-2FJ-2F8hKFOa0mujG2gwJ7JP953gbmKUInHb5HHUSfznDd-2BCGWX8VbR5v= y6fzodvntKeHEHZaV1ZgMOmuLmK69mDwGubZ9s6QbHMGIBwvBkP-2FOiS5xcAv4RkU65w-3D-3D= ) =E2=80=A2 Weekly ( https://link.skool.com/ls/click?upn=3Du001.wK6x93j= hdVos-2F3TofGJCJv2x-2FXYKi-2F266Yv7HF2lGr2lKEDUFdUmJbSqgmJ4GHGXwdeLAhi0ttQV= U-2BJn-2FSc7eLHj-2FjQ57b6DwiDwnULkhHGGM5nTBuwdENAEYeRWG40Jba3CElDV2vcKLX2Ij= WsL61NPA7YVvJ-2BV7lLeKjugkQtBEIrQ1SN83tPWnhWTsgiQaHXFWmoL-2B0X0YkcYWwv42jsf= aZYpbUK5qhZg8s-2BpMpU-3DNjTK_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNVm36Mi3FeCF= XPl9pgXHZbouoZDfMirbSqMZm-2FwCpxRYcmA17BXWTABPQMIzeWxAz4sHlnYR-2B0Ld41QUUDx= UUcJIcRW0VIex5IV8vc-2Bvl1Ku0o84lw9t0Z3ySqXoFBjA6iJGBMF5FgRvu4Zx-2B-2BxiG29O= zRR3-2FLHNRZMi9vM83iHNezo-2B4DvMgFDqMLp-2BAo-2BCYqkw9oLe44e7pMQnLfLcDhxbdF0= xBY4wvSdsMJZ-2BXr6GPOOb7q4NrS9aYjG3hjsSrLLDUQMASzUyU5XIzsdLwP1wpCg2fFqX3GPi= 2lXs9PJcDlyPnUkX-2Bxy94MGGuXJYcBNxx5JEAVHmz9pP9FRpmwrp5AVUNT9HQo-2B6qyAdFMJ= EWjeuRE5tgVYyUaZZmuYe5llUjL8uQXo-2BqpEc0HdnH3CFndhAZbaPJ7dWdD93ttLZ9QRXsQyD= MPyzEEHxkuqZTigjaZHY-2BOK8DS1ROrnEh26Gpl0fyUW3YscNsaUUnKgbgHgIuTufOg-3D-3D = )=20 Change notification settings ( https://link.skool.com/ls/click?upn=3Du001.w= K6x93jhdVos-2F3TofGJCJqYIach7-2FtMhH3n-2Fh9qG9l1PI-2Fm-2BraVkdOOdLOhb-2F-2B= 9kC6CS8L3GE-2B2twtfU-2FANqqw-3D-3DsTdz_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5e4zrNV= m36Mi3FeCFXPl9pgXHZbouoZDfMirbSqMZm-2FwCpxRYcmA17BXWTABPQMIzeWxAz4sHlnYR-2B= 0Ld41QUUDxUUcJIcRW0VIex5IV8vc-2Bvl1Ku0o84lw9t0Z3ySqXoFBjA6iJGBMF5FgRvu4Zx-2= B-2BxiG29OzRR3-2FLHNRZMi9vM83iHNezo-2B4DvMgFDqMLp-2BAo-2BCYqkw9oLe44e7pMQnL= fLcDhxbdF0xBY4wvSdsMJZ-2BXr6GPOOb7q4NrS9aYjG3hjsSrLLDUQMASzUyU5XIzsdLwP1wpC= g2fFqX3GPi2lXs9PJcDlyPnUkX-2B-2F0x-2Fa7GXo1A0H2YiLASjDr106yoZbwmOB036sT2-2F= UpyljlulGaBsrmDVc9UcI-2B8n59UZfoL2VeIRw6X8xmYUfQW60RtmCHO5o7yx-2BkJpBcsqtlB= zvjiuPHjuYhVLFTTLfWi3m9liNOngZ0RXB-2BVtsRGuPWjUnp8-2Fl05kUCWbcd-2BMJy-2FL1t= jlFmnJO-2Fh9zbdIg-3D-3D ) Start your own s k o o l ( https://link.skool.com/ls/click?upn=3Du001.wK6x9= 3jhdVos-2F3TofGJCJqYIach7-2FtMhH3n-2Fh9qG9l0GnWL4PQOS-2FZ5VkS4LpRux6cLnt8iw= WzMy60vV13NsmSkVAqQ6xINO84lL5vgJGcj25AcC730epr-2BJNkMe2b11hUGBGOEDRjk0X9uh6= 9usMpBfU47CevKCj2xPbbrrAQbVlKyWmpBwUC5bK4S5yQnUp-2Bn7ZVR9P0XvxtrxvYbnxS12vq= 4bPvD9aAV4Fhfh1iBI-2B1TBx2dtzuTT4gPjAa40ZeuV_Rp1oF-2B94kLqdQYeiHZJJNy7edAs5= e4zrNVm36Mi3FeCFXPl9pgXHZbouoZDfMirbSqMZm-2FwCpxRYcmA17BXWTABPQMIzeWxAz4sHl= nYR-2B0Ld41QUUDxUUcJIcRW0VIex5IV8vc-2Bvl1Ku0o84lw9t0Z3ySqXoFBjA6iJGBMF5FgRv= u4Zx-2B-2BxiG29OzRR3-2FLHNRZMi9vM83iHNezo-2B4DvMgFDqMLp-2BAo-2BCYqkw9oLe44e= 7pMQnLfLcDhxbdF0xBY4wvSdsMJZ-2BXr6GPOOb7q4NrS9aYjG3hjsSrLLDUQMASzUyU5XIzsdL= wP1wpCg2fFqX3GPi2lXs9PJcDlyPnUkX-2B8SbBT7nvZluksNDjQ-2BKQXPjD3O8uJpjlrizspH= 5jLBWD3OyHR77KdH3ARyv-2FywrDvkjM1h8M36-2FjcRUYN3Su4wRmCpK-2BlvqOKPHQu9S3crp= YEVZuj1FgKfndR-2BYt7IpKA8KJ3kgvN1L5Ch4hPYgvxxVf3JGllpQDgHMzz2jNRMniZgrG4g6r= 473b-2F2-2Bo-2BtHTA-3D-3D ) --631f8bd3c8591f5239b52090df7807df2a25fbf39b2144a73ca69dd83b11 Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset=utf-8 Mime-Version: 1.0
3D"group
Peptide Research Forum
3D"skool

6 new notifications

Since 8:22 am (May 3, 2026)
Here=E2=80=99s what you missed:
=20 =20
3D"user
Dani Phae (following) posted:
Why Retatrutide Often Requ= ires Higher Doses for Appetite Suppression
Why Retatrutide Often Requires Higher= Doses for Appetite Suppression A Deep Dive into the Science Behind the =E2=80=9CSlower Start=E2=80=9D What Is Retatrutide? Retatrutide is a next-generation metabolic peptide that activates three key= receptors: - GLP-1 (glucagon-like peptide-1) - GIP (glucose-dependent insulino...=20 Read more
View post
3D"user
Dani Phae (following) posted:
How Tirzepatide Reduces In= flammation in the Body
How Tirzepatide Reduces Inflammation = in the Body A Deep Dive into the Hidden Anti-Inflammatory Power of Dual Incretin Agonis= m What Is Tirzepatide? Tirzepatide is a dual incretin receptor agonist that activates both the GLP= -1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insuli= no...=20 Read more
View post
3D"user
Dani Phae (following) posted:
Methylene Blue
Methylene Blue: Mechanisms, Benefits, and Functional Applications What is Methylene Blue? Methylene Blue is a synthetic compound first developed in the late 1800s an= d originally used as a dye. Over time, it be= came one of the earliest pharmaceutical agents used in medicine. Today, it is recognized f...=20 Read more
View post
3D"user
Dani Phae (following) posted:
Top 50 Benefits of ARA-290=
What is ARA-290? ARA-290 (also known as Cibinetide) is a small peptide derived from Erythrop= oietin (EPO), but without the red blood cell=E2=80=93stimulating effects. Instead of acting on hematopoiesis, it select= ively targets the innate repair receptor (IRR)=E2=80=94a pathway involved i= n tissue protection, inflammat...=20 Read more
View post
3D"user
Dani Phae (following) posted:
Giveaways
Hey everyone =F0=9F=98=8A I=E2=80=99l= l be announcing the VIP monthly giveaway winner as well as the peptide mini= fridge giveaway for the regular group in a few days. I=E2=80=99ve just been a little busy, and I also want to make sur= e everyone has enough time to get their entries in before I close it out. Stay tuned =F0=9F=91=80=E2=9C=A8 =
View post
3D"user
Dani Phae (following) posted:
Low Cost of GLP-1=E2=80=99= s for Medicare Recipients
=
View post
Are we sending you too many emails?
We=E2=80=99re bundling up all your email notifi= cations: Daily

Change to: Hourly =20 =E2=80=A2 Weekly

Start your own skool
3D"" --631f8bd3c8591f5239b52090df7807df2a25fbf39b2144a73ca69dd83b11--